Inventor · disambiguated record
Veena Viswanath
Also filed as: VISWANATH VEENA
54 granted patents·13 pending applications·201 citations·filing 2010–2024
98Inventor score
Top patents by PatentIndex Score
67 records- 0194US9579307B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2016·Granted Feb 28, 2017·9 cites·7 claims
- 0294US8658803B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2012·Granted Feb 25, 2014·16 cites·6 claims
- 0393US10172832B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2018·Granted Jan 8, 2019·6 cites·1 claims
- 0493US9351948B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2015·Granted May 31, 2016·9 cites·7 claims
- 0593US8993780B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2013·Granted Mar 31, 2015·13 cites·4 claims
- 0692US9974772B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2017·Granted May 22, 2018·6 cites·6 claims
- 0792US8580817B21-(1-OXO-1,2,3,4-tetrahydroisoquinolin-7-YL)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulatorsBEARD RICHARD L·Filed 2012·Granted Nov 12, 2013·8 cites·13 claims
- 0891US8541577B2Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2012·Granted Sep 24, 2013·13 cites·3 claims
- 0990US8791161B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Jul 29, 2014·7 cites·14 claims
- 1089US8927544B2Benzofuran-2-sulfonamides derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Jan 6, 2015·4 cites·6 claims
- 1189US8809367B21-1-Oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2013·Granted Aug 19, 2014·5 cites·13 claims
- 1289US2024285584A1Amide derivatives of n-urea substituted amino acids as formyl peptidereceptor like-1 (fprl-1) receptor modulatorsALLERGAN INC·Filed 2023·Application pending·0 cites
- 1388US10993931B2Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2018·Granted May 4, 2021·1 cites·5 claims
- 1488US8816076B2Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2013·Granted Aug 26, 2014·9 cites·8 claims
- 1588US8492556B22,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2012·Granted Jul 23, 2013·11 cites·15 claims
- 1687US8450367B2Sulfur derivatives as chemokine receptor modulatorsYUAN HAIQING·Filed 2011·Granted May 28, 2013·7 cites·16 claims
- 1786US10799518B2Use of agonists of formyl peptide receptor 2 for treating dermatological diseasesALLERGAN INC·Filed 2019·Granted Oct 13, 2020·1 cites·12 claims
- 1886US9850264B2Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseasesALLERGAN INC·Filed 2014·Granted Dec 26, 2017·6 cites·2 claims
- 1986US8815915B2Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Aug 26, 2014·3 cites·12 claims
- 2084US10434112B2Use of agonists of formyl peptide receptor 2 for treating dermatological diseasesALLERGAN INC·Filed 2017·Granted Oct 8, 2019·3 cites·4 claims
- 2184US8822530B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Sep 2, 2014·3 cites·14 claims
- 2283US9428549B2Derivatives of N-urea substituted amino acids as formyl peptide receptor modulatorsALLERGAN INC·Filed 2014·Granted Aug 30, 2016·6 cites·13 claims
- 2383US8877804B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted Nov 4, 2014·3 cites·2 claims
- 2483US8729096B2Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulatorsALLERGAN INC·Filed 2013·Granted May 20, 2014·3 cites·14 claims
- 2583US8575207B2Method of activating regulatory T cells with alpha-2B adrenergic receptor agonistsGIL DANIEL W·Filed 2011·Granted Nov 5, 2013·5 cites·1 claims
- 2683US8440684B2Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (FPRL-1) receptor modulatorsBEARD RICHARD L·Filed 2012·Granted May 14, 2013·6 cites·13 claims
- 2782US9670150B2(2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulatorsALLERGAN INC·Filed 2013·Granted Jun 6, 2017·5 cites·8 claims
- 2882US8507560B2Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activityBEARD RICHARD L·Filed 2011·Granted Aug 13, 2013·5 cites·7 claims
- 2981US9371278B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Granted Jun 21, 2016·2 cites·13 claims
- 3081US9328067B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2013·Granted May 3, 2016·2 cites·7 claims
- 3181US8518913B2Phosphorous derivatives as chemokine receptor modulatorsYUAN HAIQING·Filed 2011·Granted Aug 27, 2013·3 cites·14 claims
- 3280US8580779B21,2-bis-sulfonamide derivatives as chemokine receptor modulatorsYUAN HAIQING·Filed 2011·Granted Nov 12, 2013·4 cites·5 claims
- 3379US10251865B2Method of activating regulatory T cells with alpha-2B adrenergic receptor agonistsALLERGAN INC·Filed 2017·Granted Apr 9, 2019·1 cites·3 claims
- 3479US8846760B2Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2014·Granted Sep 30, 2014·3 cites·8 claims
- 3579US2022202777A1Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulatorsALLERGAN INC·Filed 2021·Application pending·0 cites
- 3678US11046644B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2019·Granted Jun 29, 2021·0 cites·6 claims
- 3778US9416120B2Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Granted Aug 16, 2016·1 cites·8 claims
- 3877US10287243B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2015·Granted May 14, 2019·1 cites·9 claims
- 3977US10208071B2Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseasesALLERGAN INC·Filed 2017·Granted Feb 19, 2019·1 cites·5 claims
- 4077US9663460B2Sulfur derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2014·Granted May 30, 2017·1 cites·13 claims
- 4176US9545394B2Method of activating regulatory T cells with alpha-2B adrenergic receptor agonistsALLERGAN INC·Filed 2016·Granted Jan 17, 2017·1 cites·6 claims
- 4276US2024400501A13,4-disubstituted 3-cyclobutene-1,2-diones and use thereofALLERGAN INC·Filed 2024·Application pending·0 cites
- 4375US8653299B2Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulatorsVULIGONDA VIDYASAGAR·Filed 2012·Granted Feb 18, 2014·3 cites·10 claims
- 4474US9289420B2Method of activating regulatory T cells with alpha-2B adrenergic receptor agonistsALLERGAN INC·Filed 2013·Granted Mar 22, 2016·1 cites·8 claims
- 4574US8524745B2Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulatorsALLERGAN INC·Filed 2012·Granted Sep 3, 2013·2 cites·14 claims
- 4674US2022402866A13,4-disubstituted 3-cyclobutene-1,2-diones and use thereofALLERGAN INC·Filed 2021·Application pending·0 cites
- 4772US2021008085A1Use of agonists of formyl peptide receptor 2 for treating dermatological diseasesALLERGAN INC·Filed 2020·Application pending·0 cites
- 4872US2021000846A1Use of agonists of formyl peptide receptor 2 for treating dermatological diseasesALLERGAN INC·Filed 2020·Application pending·0 cites
- 4971US11208377B23,4-disubstituted 3-cyclobutene-1,2-diones and use thereofALLERGAN INC·Filed 2018·Granted Dec 28, 2021·0 cites·6 claims
- 5068US8741955B2D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disordersFOSTER ALAN C·Filed 2012·Granted Jun 3, 2014·1 cites·3 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Veena Viswanath files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →